Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Whitwell

Showing results (711-720 of 731) with videos related to

Pageof 74
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisGemeng Zhang, Leland Barnard, Hugo Botha, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2019
How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsyMax-Joseph Grimm, Gesine Respondek, Maria Stamelou, et al.
Neurology|June 27, 2025
An FDG-PET-Based Machine Learning Framework to Support Neurologic Decision-Making in Alzheimer Disease and Related DisordersLeland Barnard, Hugo Botha, Nick Corriveau-Lecavalier, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 28, 2008
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methodsClifford R Jack, Matt A Bernstein, Nick C Fox, et al.
The Lancet. Neurology|January 24, 2024
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysisMarianne Chapleau, Renaud La Joie, Keir Yong, et al.
Molecular & Cellular Proteomics : MCP|February 20, 2015
Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in PlasmaSusan E Abbatiello, Birgit Schilling, D R Mani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 23, 2026
Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to actionNick Corriveau-Lecavalier, Neus Falgàs, Deepti Putcha, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 14, 2017
Which ante mortem clinical features predict progressive supranuclear palsy pathology?Gesine Respondek, Carolin Kurz, Thomas Arzberger, et al.
Communications Medicine|December 12, 2025
Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working GroupHulya Ulugut, Kyan Younes, Maxime Montembeault, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2017
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaGünter U Höglinger, Gesine Respondek, Maria Stamelou, et al.
Pageof 74

Showing results (711-720 of 731) with videos related to

Sort By:
Pageof 74
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisGemeng Zhang, Leland Barnard, Hugo Botha, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2019
How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsyMax-Joseph Grimm, Gesine Respondek, Maria Stamelou, et al.
Neurology|June 27, 2025
An FDG-PET-Based Machine Learning Framework to Support Neurologic Decision-Making in Alzheimer Disease and Related DisordersLeland Barnard, Hugo Botha, Nick Corriveau-Lecavalier, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 28, 2008
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methodsClifford R Jack, Matt A Bernstein, Nick C Fox, et al.
The Lancet. Neurology|January 24, 2024
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysisMarianne Chapleau, Renaud La Joie, Keir Yong, et al.
Molecular & Cellular Proteomics : MCP|February 20, 2015
Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in PlasmaSusan E Abbatiello, Birgit Schilling, D R Mani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 23, 2026
Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to actionNick Corriveau-Lecavalier, Neus Falgàs, Deepti Putcha, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 14, 2017
Which ante mortem clinical features predict progressive supranuclear palsy pathology?Gesine Respondek, Carolin Kurz, Thomas Arzberger, et al.
Communications Medicine|December 12, 2025
Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working GroupHulya Ulugut, Kyan Younes, Maxime Montembeault, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2017
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaGünter U Höglinger, Gesine Respondek, Maria Stamelou, et al.
Pageof 74